Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.12
+0.96 (5.01%)
Mar 6, 2026, 4:08 PM HKT
Market Cap24.94B +94.9%
Revenue (ttm)1.82B -21.5%
Net Income246.00M
EPS0.35
Shares Outn/a
PE Ratio101.39
Forward PEn/a
Dividend0.00 (0.02%)
Ex-Dividend DateJun 26, 2025
Volume3,274,208
Average Volume2,069,693
Open19.10
Previous Close19.16
Day's Range18.90 - 20.64
52-Week Range9.36 - 28.70
Beta1.02
RSI44.08
Earnings DateMar 31, 2026

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provides clinical contract research organization ... [Read more]

Sector Healthcare
Founded 1995
Employees 2,652
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6127
Full Company Profile

Financial Performance

In 2024, HKG:6127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial numbers in CNY Financial Statements